{
     "PMID": "16600315",
     "OWN": "NLM",
     "STAT": "MEDLINE",
     "DCOM": "20060726",
     "LR": "20131121",
     "IS": "0031-9384 (Print) 0031-9384 (Linking)",
     "VI": "87",
     "IP": "5",
     "DP": "2006 May 30",
     "TI": "The effects of histaminergic agents in the ventral hippocampus of rats in the plus-maze test of anxiety-like behaviours.",
     "PG": "891-6",
     "AB": "It has been suggested that histamine have modulatory influence on anxiety-related behaviours both in animals and humans. Ventral hippocampus (VHC) may also be an important brain site in the modulation of fear or anxiety. In the present study, the effects of histaminergic agents on anxiety-related behaviours in the rats, using plus-maze test has been investigated. Intra-VHC administration of histamine (2.5, 5 and 7.5 microg/rat) decreased %OAT and %OAE but not locomotor activity, showing an anxiogenic response. Pretreatment of animals with either pyrilamine, a H1 receptor antagonist (10 microg/rat), or ranitidine, a H2 receptor antagonist (10 microg/rat) reverse anxiogenic response of histamine (2.5, 5 and 7.5 microg/rat). However, intra-VHC microinjection of higher doses of pyrilamine (40 microg/rat) or ranitidine (20 and 40 microg/rat) alone increased anxiety-like behaviours in rats. Our results showed that histamine may modulate anxiety-like behaviours via H1 and H2 receptors in the ventral hippocampus of the rats.",
     "FAU": [
          "Rostami, Parvin",
          "Hajizadeh-Moghaddam, Akbar",
          "Zarrindast, Mohammad-Reza"
     ],
     "AU": [
          "Rostami P",
          "Hajizadeh-Moghaddam A",
          "Zarrindast MR"
     ],
     "AD": "Department of Physiology, Tarbiat Moallem University, Tehran, Iran.",
     "LA": [
          "eng"
     ],
     "PT": [
          "Comparative Study",
          "Journal Article"
     ],
     "DEP": "20060306",
     "PL": "United States",
     "TA": "Physiol Behav",
     "JT": "Physiology & behavior",
     "JID": "0151504",
     "RN": [
          "0 (Histamine Agents)",
          "0 (Histamine H1 Antagonists)",
          "0 (Histamine H2 Antagonists)",
          "820484N8I3 (Histamine)",
          "884KT10YB7 (Ranitidine)",
          "HPE317O9TL (Pyrilamine)"
     ],
     "SB": "IM",
     "MH": [
          "Analysis of Variance",
          "Animals",
          "Behavior, Animal/drug effects",
          "Dose-Response Relationship, Drug",
          "Hippocampus/*drug effects",
          "Histamine/pharmacology",
          "Histamine Agents/*pharmacology",
          "Histamine H1 Antagonists/pharmacology",
          "Histamine H2 Antagonists/pharmacology",
          "Male",
          "Maze Learning/*drug effects",
          "Microinjections/methods",
          "Pyrilamine/*pharmacology",
          "Ranitidine/pharmacology",
          "Rats",
          "Rats, Wistar"
     ],
     "EDAT": "2006/04/08 09:00",
     "MHDA": "2006/07/27 09:00",
     "CRDT": [
          "2006/04/08 09:00"
     ],
     "PHST": [
          "2006/01/15 00:00 [received]",
          "2006/02/01 00:00 [accepted]",
          "2006/04/08 09:00 [pubmed]",
          "2006/07/27 09:00 [medline]",
          "2006/04/08 09:00 [entrez]"
     ],
     "AID": [
          "S0031-9384(06)00058-8 [pii]",
          "10.1016/j.physbeh.2006.02.001 [doi]"
     ],
     "PST": "ppublish",
     "SO": "Physiol Behav. 2006 May 30;87(5):891-6. doi: 10.1016/j.physbeh.2006.02.001. Epub 2006 Mar 6.",
     "term": "hippocampus"
}